XML 29 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Capital in Excess of Par Value [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Noncontrolling Interests [Member]
Beginning balance at Dec. 31, 2019 $ 5,215.5 $ 188.1 $ 3,825.7 $ 1,901.3 $ (759.6) $ 60.0
Beginning balance (in shares) at Dec. 31, 2019   188.1        
Net earnings 858.1     818.8   39.3
Net purchase of subsidiary shares from noncontrolling interests (6.4)         (6.4)
Dividends paid to noncontrolling interests (46.8)         (46.8)
Net change in pension asset/liability, net of taxes 0.4       0.4  
Foreign currency translation 184.1       183.7 0.4
Change in fair value of derivative instruments, net of taxes (68.1)       (68.1)  
Compensation expense related to stock option plan grants 13.6   13.6      
Common stock issued in: purchase transactions 309.1 $ 3.0 306.1      
Common stock issued in: purchase transactions (in shares)   3.0        
Stock option plans 77.7 $ 1.8 75.9      
Stock option plans (in shares)   1.8        
Employee stock purchase plan 34.2 $ 0.5 33.7      
Employee stock purchase plan (in shares)   0.5        
Deferred compensation and restricted stock 9.7 $ 0.3 9.4      
Deferred compensation and restricted (in shares)   0.3        
Cash dividends declared on common stock (348.4)     (348.4)    
Ending balance at Dec. 31, 2020 6,232.7 $ 193.7 4,264.4 2,371.7 (643.6) 46.5
Ending balance (in shares) at Dec. 31, 2020   193.7        
Net earnings 955.0     906.8   48.2
Net purchase of subsidiary shares from noncontrolling interests (6.0)         (6.0)
Dividends paid to noncontrolling interests (38.3)         (38.3)
Net change in pension asset/liability, net of taxes 19.0       19.0  
Foreign currency translation (121.0)       (122.3) 1.3
Change in fair value of derivative instruments, net of taxes 20.8       20.8  
Compensation expense related to stock option plan grants 17.5   17.5      
Common stock issued in: purchase transactions 251.3 $ 1.7 249.6      
Common stock issued in: purchase transactions (in shares)   1.7        
Stock option plans $ 67.6 $ 1.4 66.2      
Stock option plans (in shares) 1.4 1.4        
Employee stock purchase plan $ 41.2 $ 0.4 40.8      
Employee stock purchase plan (in shares)   0.4        
Shares issued to benefit plans 71.4 $ 0.6 70.8      
Shares issued to benefit plans (in shares)   0.6        
Deferred compensation and restricted stock 6.9 $ 0.4 6.5      
Deferred compensation and restricted (in shares)   0.4        
Stock issuance from public offering 1,437.9 $ 10.3 1,427.6      
Stock issuance from public offering (in shares)   10.3        
Other compensation expense 0.3   0.3      
Cash dividends declared on common stock (396.2)     (396.2)    
Ending balance at Dec. 31, 2021 $ 8,560.1 $ 208.5 6,143.7 2,882.3 (726.1) 51.7
Ending balance (in shares) at Dec. 31, 2021 208.5 208.5        
Net earnings $ 1,116.0     1,114.2   1.8
Net purchase of subsidiary shares from noncontrolling interests (3.2)         (3.2)
Dividends paid to noncontrolling interests (3.5)         (3.5)
Net change in pension asset/liability, net of taxes (12.3)       (12.3)  
Foreign currency translation (512.0)       (511.8) (0.2)
Change in fair value of derivative instruments, net of taxes 109.8       109.8  
Compensation expense related to stock option plan grants 27.9   27.9      
Common stock issued in: purchase transactions 165.5 $ 0.9 164.6      
Common stock issued in: purchase transactions (in shares)   0.9        
Stock option plans $ 76.1 $ 1.4 74.7      
Stock option plans (in shares) 1.4 1.4        
Employee stock purchase plan $ 47.6 $ 0.3 47.3      
Employee stock purchase plan (in shares)   0.3        
Shares issued to benefit plans 74.4 $ 0.5 73.9      
Shares issued to benefit plans (in shares)   0.5        
Deferred compensation and restricted stock (21.9) $ 0.3 (22.2)      
Deferred compensation and restricted (in shares)   0.3        
Cash dividends declared on common stock (434.3)     (434.3)    
Ending balance at Dec. 31, 2022 $ 9,190.2 $ 211.9 $ 6,509.9 $ 3,562.2 $ (1,140.4) $ 46.6
Ending balance (in shares) at Dec. 31, 2022 211.9 211.9